Blonder Tongue Laboratories, Inc.
BDRL
$0.21
$0.000.00%
09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
---|---|---|---|---|---|
Revenue | 5.26M | 4.23M | 3.34M | 3.99M | 4.17M |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 5.26M | 4.23M | 3.34M | 3.99M | 4.17M |
Cost of Revenue | 3.85M | 3.17M | 2.40M | 2.62M | 2.67M |
Gross Profit | 1.41M | 1.06M | 939.00K | 1.37M | 1.50M |
SG&A Expenses | 1.50M | 1.52M | 1.42M | 1.48M | 1.54M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | 0.00 | -619.00K |
Total Operating Expenses | 5.74M | 5.20M | 4.36M | 4.77M | 4.26M |
Operating Income | -475.00K | -962.00K | -1.02M | -777.00K | -84.00K |
Income Before Tax | -703.00K | -1.15M | -1.15M | -912.00K | -201.00K |
Income Tax Expenses | -- | -- | -- | 15.00K | -- |
Earnings from Continuing Operations | -703.00K | -1.15M | -1.15M | -927.00K | -201.00K |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -703.00K | -1.15M | -1.15M | -927.00K | -201.00K |
EBIT | -475.00K | -962.00K | -1.02M | -777.00K | -84.00K |
EBITDA | -453.00K | -936.00K | -966.00K | -697.00K | -2.00K |
EPS Basic | -0.05 | -0.09 | -0.09 | -0.07 | -0.02 |
Normalized Basic EPS | -0.03 | -0.05 | -0.05 | -0.04 | -0.01 |
EPS Diluted | -0.05 | -0.09 | -0.09 | -0.09 | -0.02 |
Normalized Diluted EPS | -0.03 | -0.05 | -0.05 | -0.04 | -0.01 |
Average Basic Shares Outstanding | 13.33M | 13.32M | 13.13M | 12.74M | 12.23M |
Average Diluted Shares Outstanding | 13.33M | 13.32M | 13.13M | 12.74M | 12.23M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |